Adrenomed was featured in the Deutsche Welle report “On the wave of BioNTech success – is it becoming easier to get financing for innovation?” Check out the video with Andreas Bergmann, CSO, and Frauke Hein,
April 2021, by Stephen Hansen
September 2020, by Cormac Sheridan
August 2020, by Cormac Sheridan Read the full article here.
February 2020, by Michael Flanagan
February 2020, by Cormac Sheridan
Article in BioCentury Innovation: Adrenomed looks beyond immune modulators for sepsis, aims for shock prevention
October 2019, by Lauren Martz and Inhua Muijrers-Chen, Associate Editors
Article in GoingPublic Special Issue: Case Study “Mit einem gefäßschützenden Antikörper gegen septischen Shock”
Read the full article about Adrenomed on page 104 of the GoingPublic Special Issue “Biotechnologie 2019” (Article in German). Illustration: Adrenomed AG
Article in BioWorld: Adrenomed readies for success as lead drug adrecizumab clears interim hurdle in sepsis trial
April 2019 by Cormac Sheridan, Staff Writer.